Skip to Content
Merck
  • Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide.

Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide.

Pediatric blood & cancer (2005-12-08)
Seong L Khaw, Peter A Downie, Keith D Waters, David M Ashley, John A Heath
ABSTRACT

Mesna is widely used for the prevention of cyclophosphamide-related hemorrhagic cystitis. It has been associated with hypersensitivity-like cutaneous and systemic reactions in adult patients. We report a series of children with malignant disease, who developed such reactions following mesna administration and discuss possible mechanisms and management issues.